mild
central
nervou
system
cn
symptom
headach
drowsi
result
system
elev
cytokin
level
therefor
common
mani
viru
infect
even
absenc
infect
cn
chapter
shall
consid
virus
known
infect
cn
polioviru
member
picornaviru
famili
enteroviru
genu
major
scourg
earlier
part
twentieth
centuri
genu
name
indic
viru
replic
gastrointestin
tract
usual
transmit
fecal
oral
rout
viremia
common
vast
major
infect
remain
asymptomat
cn
infect
quit
unusu
initi
either
result
viremia
rare
neural
spread
viru
infect
anterior
horn
motor
neuron
spinal
cord
caus
poliomyel
greek
polio
plu
myelo
inflamm
gray
marrow
diseas
viru
name
loss
cell
result
paralysi
often
lower
limb
case
infect
ascend
cord
caus
paralysi
upper
limb
extrem
case
infect
reach
junction
spinal
cord
brain
result
paralysi
muscl
respir
bulbar
palsi
requir
victim
place
iron
lung
develop
kill
live
polio
vaccin
massiv
reduc
frequenc
infect
associ
diseas
program
direct
world
health
organ
aim
erad
polioviru
within
next
year
success
second
viru
follow
smallpox
extermin
vaccin
pathogenesi
murin
equival
polioviru
theiler
viru
extens
studi
describ
later
chapter
herpesvirus
probabl
commonest
virus
infect
neuron
tissu
herp
simplex
viru
hsv
varicellazost
viru
vzv
establish
latent
infect
dorsal
root
ganglia
peripher
nervou
system
particularli
immunocompromis
reactiv
dissemin
caus
enceph
commonli
vesicular
erupt
skin
area
innerv
infect
neuronslead
cold
soresfev
blister
hsv
shingl
vzv
epsteinbarr
viru
ebv
caus
infecti
mononucleosi
also
associ
rare
enceph
andersson
et
al
schiffet
al
measl
viru
negativestrand
rna
viru
member
morbilliviru
genu
infect
viru
commonli
result
characterist
rash
immunopatholog
mediat
direct
viral
cytotox
instead
cell
respons
host
howev
organ
frequent
affect
giant
cell
pneumonia
lethal
cn
infect
infrequ
mening
enceph
occur
postinfecti
encephalomyel
occur
case
usual
occur
within
week
infect
howev
difficult
detect
viru
cn
suggest
observ
perivenular
demyelin
immunemedi
gendelman
et
al
rare
complic
x
case
subacut
scleros
panenceph
sspe
measl
viru
rna
protein
persist
glial
cell
neuron
lead
cn
dysfunct
death
iceland
virologist
bjorn
sigurdsson
carri
epidemiolog
studi
sheep
diseas
rida
sigurdsson
commonli
known
english
term
scrapi
visna
suggest
infecti
origin
incub
period
much
longer
standard
virus
sigurdsson
led
propos
new
categori
viru
slow
viru
slow
viral
diseas
observ
mani
speci
includ
human
cn
diseas
kuru
first
describ
papua
new
guinea
incub
period
measur
year
mani
year
curiou
clinic
defin
categori
virus
remain
devoid
molecularli
character
member
eventu
becam
clear
group
encompass
sever
differ
agent
agent
rel
standard
virus
agent
includ
agent
scrapi
refractori
categor
stanley
prusin
groundbreak
identif
prion
describ
section
one
firstcharacter
slow
virus
retroviru
caus
visna
inde
long
incub
period
gave
viru
group
name
lentivirus
latin
word
lentu
slow
human
immunodefici
viru
hiv
lentiviru
common
group
diseas
often
appear
mani
year
postexposur
later
stage
hiv
infect
frequent
character
enceph
dementia
fox
et
al
moller
et
al
wiley
et
al
viru
member
rhabdoviru
famili
kill
peopl
annual
transmit
saliva
infect
anim
usual
bite
viru
may
undergo
local
replic
site
inocul
perhap
muscl
cell
key
featur
subsequ
centripet
spread
cn
within
neuron
axon
viremia
promin
featur
diseas
prevent
physic
chemic
interrupt
axon
transport
ceccaldi
et
al
tsiang
reach
cn
viru
spread
within
brain
often
result
negri
bodi
format
especi
hippocampu
howev
detect
histolog
damag
often
less
extens
might
expect
given
sever
neurolog
behavior
symptom
observ
term
rabi
deriv
latin
term
mad
cn
infect
establish
viru
may
spread
centrifug
variou
tissu
includ
salivari
gland
secret
saliva
famili
includ
varieti
human
pathogen
caus
hemorrhag
fever
lassa
junin
machupo
virus
prototyp
famili
lymphocyt
choriomening
viru
lcmv
infect
human
frequent
often
realiz
viru
rodentborn
recent
survey
baltimor
indic
hous
mice
human
seroposit
child
et
al
child
et
al
spectrum
human
diseas
rang
subclin
infect
fatal
meningoenceph
viru
teratogen
lead
hydrocephalu
larsen
et
al
immunobiolog
pathogenesi
lcmv
infect
extens
studi
use
model
evalu
dna
immun
describ
later
chapter
arbovirus
arthropodborn
virus
import
human
pathogen
caus
exampl
yellow
fever
dengu
hemorrhag
fever
unit
state
primari
clinic
manifest
arbovir
diseas
enceph
mani
virus
sever
differ
viral
famili
implic
mosquitoborn
transmit
tick
commonli
diagnos
arbovir
enceph
unit
state
caus
flaviviru
st
loui
enceph
sle
viru
howev
underestim
capac
virus
enter
new
ecolog
nich
outbreak
viral
enceph
new
york
septemb
initi
ascrib
sle
subsequ
attribut
west
nile
viru
previous
identifi
countri
arbovir
encephalitid
includ
caus
western
equin
venezuelan
equin
enceph
virus
alphavirus
california
group
enceph
virus
bunyavirus
borna
diseas
viru
bdv
prototyp
new
famili
negativestrand
rna
viru
bries
et
al
de
la
torr
viru
caus
immunemedi
enceph
mani
speci
planz
et
al
stitz
et
al
infecti
bdv
identifi
human
antibodi
protein
nucleic
acid
identif
sera
andor
cn
patient
suffer
certain
psychiatr
disord
bode
et
al
de
la
torr
et
al
de
la
torr
et
al
rais
intrigu
possibl
psychos
may
virusinduc
chapter
book
devot
bdv
neurotrop
consequ
also
describ
elsewher
volum
coronaviru
infect
cn
final
viral
diseas
cn
includ
progress
multifoc
leukoencephalopathi
pml
caus
papillomaviru
jc
human
carri
antibodi
specif
viru
pml
usual
seen
immunosuppress
patient
consequ
incid
pml
increas
parallel
hiv
infect
dorri
gordon
khalili
jensen
major
weber
major
mention
agent
extrem
protract
incub
period
prion
protein
prp
first
identifi
part
proteaseresist
materi
propos
prusin
proteinonli
infecti
agent
respons
scrapi
transmiss
spongiform
encephalopathi
tse
heret
notion
engend
justifi
skeptic
among
mani
expert
resist
numer
challeng
evid
favor
strong
prp
gene
encod
cellular
protein
express
mani
cell
type
includ
neuron
cell
immun
system
whose
normal
function
remain
uncertain
mice
lack
gene
prpko
mice
detect
cn
abnorm
bueler
et
al
kuwahara
et
al
express
gene
prerequisit
host
suscept
tse
agent
prpko
mice
resist
challeng
bueler
et
al
prusin
et
al
host
protein
exist
least
two
conform
distinguish
sensit
proteas
proteasesensit
form
appear
normal
conform
present
normal
host
caus
diseas
proteaseresist
form
appear
infecti
prion
replic
infect
appear
determin
abil
pathogen
conform
initi
conform
chang
normal
counterpart
key
prion
diseas
underpin
replic
agent
infect
host
transmiss
absenc
nucleic
acid
conform
chang
recent
demonstr
tissu
cultur
studi
bessen
et
al
kocisko
et
al
kocisko
et
al
tse
transfer
new
host
misfold
protein
use
normal
protein
new
host
substrat
product
abnorm
conform
gene
permit
replic
novel
form
infecti
pathogen
therefor
provid
unwit
victim
unusu
contain
nucleic
acid
genom
instead
prion
infecti
protein
encod
host
prp
gene
protein
exist
least
two
conform
one
normal
seem
serv
function
cn
abnorm
abnorm
conform
infecti
appear
abl
act
templat
caus
normal
sibl
convert
abnorm
accumul
abnorm
conform
lead
spongiform
encephalopathi
histolog
hallmark
prion
diseas
histor
relationship
slow
virus
prion
often
result
inclus
prion
virolog
textbook
inde
topic
two
chapter
volum
radic
differ
code
strategi
host
gene
b
mode
replic
direct
misfold
selfprotein
abnorm
conform
c
mechan
infect
infecti
protein
sure
render
uniqu
despit
question
membership
viru
taxon
mention
caus
cn
diseas
recent
studi
suggest
immun
may
modifi
cn
diseas
character
abnorm
deposit
selfprotein
caus
certain
cn
diseas
remain
unknown
exampl
multipl
sclerosi
ms
degen
diseas
cn
character
demyelin
clinic
histolog
featur
ms
vari
relapsingremit
diseas
chronic
progress
role
might
virus
play
first
ms
may
result
persist
viru
infect
act
drive
chronic
immun
respons
past
sever
decad
variou
virus
advanc
caus
ms
date
none
suggest
withstood
analysi
result
enthusiasm
hypothesi
perhap
diminish
howev
unlik
ms
result
persist
infect
known
viru
possibl
caus
viru
yet
identifi
may
tempt
think
millennium
identifi
microb
associ
infect
estim
extant
bacteria
catalog
new
virus
continu
identifi
inde
even
entir
viru
famili
discov
past
decad
eg
bornavirida
mention
anim
human
develop
ms
true
autoimmun
diseas
exampl
human
anim
develop
diabet
arthriti
thyroid
thu
ms
could
caus
microb
whose
host
rang
tightli
restrict
human
howev
second
popular
hypothesi
implic
autoimmun
ms
like
sever
autoimmun
diseas
common
women
men
number
idea
advanc
explain
virusinduc
autoimmun
recent
review
oldston
includ
releas
infect
cell
sequest
host
protein
act
autoantigen
see
chapter
epitop
spread
book
consist
antibodi
cell
specif
cn
selfantigen
detect
cn
ms
patient
healthi
individu
thought
ms
may
initi
infect
one
viru
subsequ
infect
unrel
virus
might
oost
immun
respons
releas
cn
selfantigen
proposit
support
appar
associ
relaps
ms
recent
infect
howev
one
could
argu
relaps
caus
instead
transient
immunosuppress
accompani
viru
infect
result
reactiv
unidentifi
persist
latent
viru
thu
pathogenesi
ms
remain
uncertain
mani
research
feel
virus
play
role
initi
mainten
diseas
chapter
volum
devot
import
topic
evalu
role
dna
immun
protect
viral
infect
cn
relat
diseas
must
first
consid
immun
system
recogn
virus
virusinfect
cell
deal
challeng
topic
recent
summar
whitton
oldston
immun
respons
viru
infect
divid
two
compon
innat
respons
adapt
respons
serial
express
partial
overlap
tempor
phase
soon
host
first
infect
viru
innat
immun
respons
activ
mani
cell
secret
interferon
natur
killer
nk
cell
rare
activ
macrophag
secret
interferoni
ifni
ifni
also
import
effector
molecul
releas
cell
antigenspecif
phase
immun
respons
describ
detail
upon
exposur
cytokin
noninfect
cell
render
resist
viru
infect
interferon
therefor
limit
abil
viru
spread
local
meantim
nk
cell
popul
expand
usual
peak
approxim
day
postinfect
cell
specif
detect
virusinfect
cell
instead
trigger
combin
factor
poorli
character
stimulatori
molecul
absenc
class
major
histocompat
complex
mhc
molecul
innat
respons
wane
adapt
respons
expand
adapt
respons
differ
innat
two
key
way
first
adapt
respons
antigenspecif
recogn
specif
structur
usual
protein
occasion
carbohydr
glycolipid
virus
virusinfect
cell
second
adapt
respons
exhibit
memori
antigenspecif
cell
maintain
long
infect
clear
memori
cell
permit
rapid
elev
respons
host
reexpos
antigen
antigenspecif
memori
form
cornerston
vaccin
vaccin
induc
memori
cell
specif
appropri
antigen
cell
respond
rapidli
host
encount
relat
pathogen
chapter
devot
vaccin
shall
focu
adapt
immun
respons
antigenspecif
immun
reli
lymphocyt
two
type
b
lymphocyt
produc
antibodi
lymphocyt
antibodi
recogn
antigen
region
hypervari
sequenc
crystallograph
analys
antibodyantigen
union
indic
union
hand
glove
compon
extent
alter
conform
accommod
one
anoth
lock
key
element
fix
unabl
modul
arevalo
et
al
rini
et
al
rule
play
part
host
immun
antibodi
recogn
intact
protein
thu
antibodi
interact
bacteria
virus
well
viral
protein
often
glycoprotein
express
surfac
infect
cell
virus
oblig
intracellular
parasit
usual
transmit
associ
cell
rather
free
infecti
particl
sinc
antibodi
recogn
free
virus
easi
see
antibodi
play
major
role
control
viru
infect
inactiv
viru
enter
cell
antibodi
play
extrem
import
part
antivir
immun
inde
mani
case
administr
specif
antibodi
confer
complet
protect
subsequ
challeng
relev
viru
passiv
transfer
antibodi
remain
import
compon
medic
treatment
patient
expos
certain
virus
eg
rabi
antibodi
neutral
virus
number
way
may
bind
part
viru
interact
cellsurfac
receptor
prevent
viru
attach
cell
may
agglutin
mani
infecti
particl
singl
clump
thu
reduc
number
cell
becom
infect
virus
may
activ
complement
directli
indirectli
via
antibodi
releas
chemotact
factor
note
intact
antibodi
prerequisit
antivir
effect
fab
fragment
specif
respiratori
syncyti
viru
rsv
f
glycoprotein
instil
lung
infect
mice
therapeut
effect
crow
et
al
approach
hold
promis
particularli
light
recent
advanc
technolog
allow
rapid
product
antibodi
desir
specif
kang
et
al
five
differ
class
antibodi
immunoglobulin
ig
igg
igm
igd
ige
differ
function
attribut
natur
infect
virus
gain
entri
via
respiratori
enter
mucos
surfac
therefor
surpris
mucos
immun
particular
secretori
iga
play
import
role
control
viral
infect
ogra
garofalo
pentamer
decaval
igm
molecul
produc
earli
viru
infect
usual
independ
cell
help
act
initi
antibodymedi
system
antivir
respons
later
infect
secondari
exposur
igmproduc
cell
switch
produc
igg
antigen
specif
major
complementbind
opson
antibodi
human
spiegelberg
complex
virus
igg
also
facilit
fc
receptormedi
phagocytosi
monocyt
macrophag
polymorphonuclear
leukocyt
even
cell
entri
antibodi
exert
effect
viru
infect
interact
viral
protein
often
glycoprotein
surfac
infect
cell
lyse
infect
cell
associ
complement
modul
intracellular
viral
replic
fujinami
oldston
relev
chapter
suggest
neuron
viru
infect
erad
antibodi
without
damag
neuron
levin
et
al
mechan
remain
undefin
howev
mani
virus
delay
glycoprotein
express
late
infect
cycl
viral
matur
may
occur
point
antibodymedi
effect
may
biolog
inconsequenti
host
detect
virusinfect
cell
earli
infect
process
thu
maxim
immunolog
advantag
antibodi
less
effect
limit
recognit
requir
wherea
cell
play
critic
role
detail
cell
categor
surfac
marker
protein
express
major
cell
cytotox
lymphocyt
ctl
although
cell
nonlyt
exert
antivir
effect
cytokin
releas
levi
et
al
cell
helper
cell
secret
cytokin
assist
b
cell
matur
perhap
aid
develop
cell
respons
cell
recogn
antigen
via
cell
surfac
heterodim
tcell
receptor
tcr
molecul
structur
reminisc
fab
portion
antibodi
molecul
natur
cell
recognit
differ
antibodi
recognit
one
critic
aspect
antibodi
recogn
antigen
isol
cell
react
antigen
form
short
peptid
present
host
glycoprotein
encod
mhc
two
major
class
mhc
molecul
class
class
ii
close
relationship
class
mhcpeptid
complex
recogn
cell
surfac
marker
born
cell
mhc
class
molecul
classic
molecul
associ
graft
reject
phenomenon
gave
mhc
name
express
somat
cell
interact
cell
bear
surfac
marker
contrast
mhc
class
ii
molecul
much
restrict
express
found
special
antigenpres
cell
eg
macrophag
b
lymphocyt
dendrit
cell
interact
cell
carri
surfac
marker
target
cell
surfac
class
class
ii
molecul
similar
overal
structur
class
heterodim
compris
class
heavi
h
chain
close
complex
nonmhcencod
protein
class
ii
heterodim
consist
two
similar
chain
class
class
ii
form
structur
graphic
describ
venu
fli
trap
groov
bind
antigen
peptid
sequencespecif
manner
present
cell
surfac
perus
oft
cell
bjorkman
et
al
bjorkman
et
al
although
superfici
similar
two
type
mhcpeptid
complex
differ
reach
cell
surfac
mhc
class
optim
present
intracellular
antigen
mhc
class
ii
present
antigen
captur
extracellular
milieu
thu
cell
distinguish
peptideclass
complex
peptideclass
ii
complex
realli
discrimin
basi
sourc
peptid
peptid
deriv
protein
made
within
cell
protein
taken
extracellular
space
mhc
class
pathway
vital
recognit
virusinfect
cell
viral
protein
synthes
degrad
within
cell
result
peptid
transport
endoplasm
reticulum
encount
empti
mhc
class
molecul
peptid
suffici
affin
particular
mhc
allel
bind
groov
attach
stabil
complex
trimolecular
structur
travel
cell
membran
screen
cell
host
cell
effector
arm
antivir
cell
respons
therefor
assum
great
signific
antivir
immun
respons
one
major
advantag
arrang
cell
recogn
almost
viral
protein
long
contain
peptid
sequenc
present
mhc
class
therefor
even
protein
express
begin
viral
life
cycl
limit
cytosol
vulner
degrad
mhc
class
present
way
host
identifi
erad
infect
cell
earli
stage
long
viral
matur
occur
exampl
major
ctl
respons
human
cytomegaloviru
hcmv
direct
protein
express
immedi
infect
similar
situat
exist
vzv
hsv
defect
mhc
class
antigenprocess
pathway
may
result
infect
cell
unabl
present
viral
peptid
cell
membran
turn
would
render
viru
invis
cell
antibodi
import
limit
number
infect
cell
clear
viru
host
cell
respons
play
critic
role
control
mani
viru
infect
cell
extens
character
anim
model
result
equat
well
obtain
human
studi
although
role
cell
control
primari
viru
infect
recogn
time
import
cell
vaccineinduc
protect
immun
often
disregard
mani
studi
shown
vaccineinduc
cell
respons
absenc
vaccineinduc
antibodi
respons
suffici
confer
solid
protect
immun
subsequ
viru
challeng
exampl
lcmv
mous
model
recombin
vaccin
contain
minigen
encod
isol
lcmv
ctl
epitop
short
residu
confer
protect
normal
lethal
dose
challeng
viru
differ
epitop
link
string
bead
protect
sever
mhc
background
whitton
whitton
et
al
lcmvspecif
antibodi
respons
induc
vaccin
prove
protect
effect
mediat
cellular
immun
respons
cell
also
import
control
human
viral
diseas
ebv
infect
transform
human
b
lymphocyt
control
cell
popul
appear
manag
larg
part
virusspecif
cell
inde
immunosuppress
individu
lack
cell
may
develop
ebv
lymphomata
rickinson
et
al
mark
cell
respons
also
found
influenza
viru
measl
viru
mump
respiratori
syncyti
viru
human
immunodefici
viru
agent
two
major
effector
mechan
underli
vivo
antivir
effect
virusspecif
cell
cell
lysi
cytokin
releas
virusspecif
cell
lyse
infect
target
cell
thu
justifi
name
ctl
ctl
contain
protein
perforin
podack
et
al
releas
contact
infect
cell
selfassembl
transmembran
pore
penetr
cytoplasm
membran
target
cell
lead
cell
death
transgen
mice
dysfunct
perforin
gene
much
less
effect
control
infect
though
virus
kagi
et
al
kagi
et
al
walsh
et
al
furthermor
virusspecif
cell
induc
apoptot
lysi
fa
ligand
fasl
protein
express
cell
membran
suda
nagata
interact
fa
protein
infect
cell
initi
signal
cascad
end
target
cell
death
shresta
et
al
welsh
et
al
zychlinski
et
al
cell
releas
antivir
cytokin
mani
cell
releas
high
level
cytokin
exampl
interferon
ifn
tumor
necrosi
factora
tnfa
mice
lack
ifn
receptor
increas
suscept
sever
infect
despit
appar
normal
ctl
th
respons
huang
et
al
cogent
argu
major
role
tcrmhcpeptid
interact
simpli
hold
cell
immedi
proxim
virusinfect
cell
thu
focus
cytokin
infect
cell
ramsay
et
al
rubi
ramshaw
convinc
data
mice
persist
infect
lcmv
oldston
et
al
tishon
et
al
hepat
b
viru
hbv
transgen
mice
guidotti
chisari
guidotti
et
al
hbvinfect
primat
guidotti
et
al
shown
viral
materi
erad
vivo
neuron
oldston
et
al
tishon
et
al
hepatocyt
guidotti
chisari
guidotti
et
al
absenc
cytolysi
avail
two
cell
effector
mechan
allow
us
consid
viru
infect
might
ideal
handl
host
follow
scenario
shall
consid
two
interact
variabl
first
pathogen
viru
second
resili
infect
organ
consid
cell
infect
highli
lytic
viru
intuit
may
seem
host
attempt
lyse
doom
cell
cell
die
soon
earli
lysi
may
benefit
host
destroy
viru
factori
thu
prevent
releas
infecti
particl
mani
organ
precis
happen
often
cell
lyse
later
replac
exampl
regen
power
liver
legendari
estim
hepatocyt
produc
daili
replenish
cell
lost
hbv
infect
nowak
et
al
furthermor
even
tissu
regener
incomplet
host
organ
suffici
function
redund
allow
host
toler
loss
signific
proport
organ
mass
exampl
toler
loss
kidney
function
suffer
sign
symptom
renal
failur
howev
tissu
neither
regener
function
appropri
compon
lost
tissu
would
make
sens
host
lyse
infect
cell
would
better
take
risk
viru
lytic
consign
cell
certain
immunopatholog
death
sinc
host
presum
forese
lytic
capac
infecti
agent
face
dilemmashould
kill
infect
cell
benefici
tissu
lytic
nonlyt
virus
instead
secret
cytokin
allow
infect
cell
surviv
possibl
benefici
nonlyt
infect
organ
minim
regen
capac
host
toler
cell
loss
render
choic
meaning
cell
respons
would
abl
mount
respons
nonlyt
natur
thu
provid
capac
cytokinemedi
antivir
effect
permit
surviv
infect
cell
evid
exist
nonlyt
cell
blackbourn
et
al
levi
et
al
mani
dna
rna
virus
establish
infect
cn
often
neuron
case
like
reason
cn
cell
immun
privileg
less
open
immun
surveil
organ
cell
type
intuit
make
sens
cn
neuron
nondivid
cell
histor
consid
irreplac
although
recent
find
indic
neuron
pathway
may
resili
plastic
previous
thought
clear
nevertheless
host
ill
afford
lose
vital
cell
neuron
access
somat
cell
follow
viru
infect
would
suscept
lysi
virusspecif
ctl
suffici
class
ipeptid
complex
express
discuss
perhap
limit
destruct
evolut
render
neuron
less
open
immun
surveil
much
cn
resid
behind
bloodbrain
barrier
resist
passag
cell
even
mani
molecul
result
cn
biochem
cellularli
distinct
organ
bloodbrain
barrier
topic
anoth
chapter
volum
analyz
vitro
neuron
show
minim
transcript
surfac
express
class
mhc
although
induc
joli
et
al
lampson
et
al
lampson
fisher
neumann
et
al
furthermor
neuron
differ
cell
type
fail
express
sever
compon
class
antigen
present
pathway
eg
tap
transport
joli
oldston
interestingli
ifni
upregul
molecul
along
class
heavi
chain
lead
cellsurfac
express
peptidemhc
complex
contrast
tnfa
upregul
transcript
class
variou
accessori
molecul
therefor
increas
cell
surfac
class
ipeptid
express
follow
exposur
extrem
toxic
cytokin
neumann
et
al
recent
shown
differ
popul
virusspecif
cell
select
express
ifni
tnfa
tempt
suggest
interact
infect
neuron
particular
subpopul
virusspecif
cell
cn
might
secret
tnfa
ifn
therebi
permit
erad
viru
without
caus
extens
disrupt
immun
recognit
statu
neighbor
cn
cell
furthermor
recent
analyz
regul
cytokin
synthesi
antigenspecif
cell
shown
exquisit
sensit
antigen
contact
slifka
et
al
even
height
infect
cytokin
synthesi
turn
vast
major
virusspecif
cell
transcript
cytokin
mrna
begin
immedi
upon
antigen
contact
cytokin
product
termin
instantli
upon
antigen
disengag
thu
cell
produc
cytokin
direct
contact
appropri
peptidemhc
complex
one
specul
may
evolutionari
advantag
arrang
cn
cytokin
ifni
upregul
cellsurfac
express
class
mhc
may
disadvantag
host
cell
produc
ifni
promiscu
manner
might
lead
display
mhc
complex
cell
throughout
cn
tight
regul
cytokin
product
ensur
risk
minim
cours
vitro
result
may
reflect
normal
statu
respons
neuron
vivo
howev
vivo
studi
shown
normal
circumst
cn
neuron
whether
lie
within
outwith
bloodbrain
barrier
exhibit
lowtoundetect
level
mhc
class
lampson
hickey
whelan
et
al
gangliosid
glycosphingolipid
long
thought
modul
immun
respons
mount
nk
cell
bergelson
et
al
bergelson
bergelson
recent
work
discuss
anoth
chapter
indic
molecul
may
contribut
immunosuppress
milieu
cn
viru
infect
irani
et
al
irani
therefor
possibl
activ
virusspecif
cell
enter
cn
function
impair
interact
complex
lipid
abund
tissu
vaccin
design
prevent
infect
diminish
frequenc
sever
diseas
immun
viral
induc
cn
diseas
necessarili
requir
induct
immun
within
cn
perhap
best
exampl
polio
vaccin
induc
strong
antibodymedi
mucos
immun
vaccine
ingest
viral
contamin
materi
antibodi
either
prevent
enter
infect
els
radic
reduc
level
viru
replic
gastrointestin
tract
two
benefit
first
infect
individu
less
like
develop
sever
viremia
turn
greatli
diminish
risk
cn
infect
diseas
second
infect
host
excret
less
viru
thu
reduc
risk
infect
suscept
neighbor
thu
polio
vaccin
protect
individu
commun
poliomyel
without
induc
cnsspecif
immun
respons
vaccine
inde
none
current
avail
vaccin
diseas
review
section
chapter
known
induc
respons
cn
work
induc
system
immun
limit
infect
viral
replicationdissemin
mani
way
encourag
impli
success
vaccin
overcom
immun
privileg
present
healthi
cn
argu
cn
immuneprivileg
site
must
acknowledg
privileg
incomplet
inde
implicit
fact
viru
infect
result
enceph
inflammatori
respons
particularli
presenc
virusspecif
lymphocyt
unequivoc
evid
immun
privileg
breach
anim
model
reveal
much
immun
respons
take
place
cn
shall
describ
two
model
lcmv
theiler
viru
studi
laboratori
viru
infect
allow
us
demonstr
differ
facet
immun
respons
cn
arenaviru
caus
asept
mening
human
mice
mous
model
choriomening
consist
achiev
intracrani
inocul
low
dose
viru
pfu
plaqueform
unit
mice
appear
essenti
normal
day
sixth
day
becom
ill
ruffl
fur
hunch
postur
reduc
mobil
die
day
analysi
cerebrospin
fluid
reveal
massiv
lymphocyt
infiltr
shown
fig
domin
cell
whose
deplet
permit
mous
surviv
dixon
et
al
therefor
lethal
lcm
good
exampl
cellmedi
immunopatholog
although
lethal
outcom
ctldepend
cell
confer
protect
infect
diseas
allan
doherti
inde
state
vaccin
encod
singl
ctl
epitop
protect
subsequ
intracrani
lcmv
challeng
klavinski
et
al
whitton
et
al
appar
anomali
explain
consid
rel
kinet
viru
infect
immun
respons
previous
naiv
mous
viru
replic
origin
infect
cell
absenc
establish
ctl
respons
free
dissemin
throughout
choriomening
time
virusspecif
ctl
respons
amplifi
meaning
level
choriomening
cell
heavili
infect
shown
fig
lb
ctl
respons
therefor
intens
extens
fig
result
death
host
contrast
mous
success
vaccin
induc
epitopespecif
ctl
acceler
ctl
respons
quickli
limit
viru
replic
spread
although
mous
show
sign
morbid
around
day
presum
result
mild
mening
viru
clear
day
anim
make
complet
recoveri
kinet
immun
respons
crucial
respons
induc
low
diseas
may
fact
exacerb
oehen
et
al
surprisingli
still
know
precis
naiv
anim
succumb
lcmv
challeng
mice
lack
perforin
gene
surviv
despit
mount
strong
virusspecif
cell
respons
lead
histolog
choriomening
kagi
et
al
walsh
et
al
indic
abrog
cell
lytic
activ
suffici
prevent
death
even
presenc
infiltr
hypothes
proven
death
result
perforinmedi
destruct
choroid
plexu
lead
dysregul
bloodcsf
interfac
theiler
murin
encephalomyel
viru
tmev
singlestrand
positivesens
rna
viru
virus
separ
two
gener
group
depend
neurovirul
highli
neurovirul
strain
includ
gdvii
fa
virus
littl
pfu
inject
intracrani
caus
massiv
infect
limbic
system
particularli
hippocampu
fig
kill
mous
day
neuron
die
apoptosi
tsunoda
et
al
contrast
infect
mice
less
neurovirul
strain
da
ww
bean
virus
lead
acut
polioencephalomyel
follow
chronic
inflammatori
demyelin
diseas
interest
featur
less
virul
infect
cn
distribut
lesion
viru
alter
infect
transit
acut
phase
chronic
phase
acut
phase
infect
suscept
mice
viral
antigen
rna
found
mostli
neuron
gray
matter
inflamm
also
exclus
present
gray
matter
contrast
chronic
phase
virusinfect
cell
inflamm
accompani
demyelin
primarili
detect
white
matter
spinal
cord
fig
yamada
et
al
still
clear
whether
astrocyt
oligodendrocyt
microgli
cell
macrophag
combin
thereof
primari
site
viru
persist
resist
chronic
theiler
viru
diseas
map
mhc
class
region
review
yamada
et
al
mhc
class
irestrict
ctl
specif
capsid
protein
found
resist
mice
indic
mhc
class
irestrict
virusspecif
ctl
import
clearanc
infect
sinc
mhc
class
express
upregul
cn
theiler
viru
infect
hypothes
ctl
respons
elimin
viru
acut
phase
neuron
infect
earli
acut
phase
infect
phase
mhc
class
molecul
express
glial
endotheli
cell
neuron
altinta
et
al
lindsley
et
al
therefor
resist
mice
ctl
may
play
role
clear
viru
macrophag
andor
glial
cell
result
protect
mice
chronic
stage
toler
induct
mice
regard
myelin
alter
develop
inflammatori
demyelin
lesion
characterist
theiler
mous
encephalomyel
lang
et
al
howev
toler
induct
regard
theiler
viru
prevent
develop
clinic
diseas
includ
inflamm
demyelin
suggest
h
chronic
immunopathogen
diseas
direct
viru
antigen
persist
cn
karpu
et
al
clinic
patholog
featur
mimic
h
u
n
demyelin
diseas
ms
appear
cell
contribut
tmevinduc
inflammatori
demyelin
diseas
therefor
infect
mice
less
neurovirul
strain
tmev
use
experiment
anim
model
progress
form
ms
dna
vaccin
rel
new
entrant
vaccin
sweepstak
view
optim
number
reason
topic
review
hassett
whitton
liu
et
al
follow
advantag
dna
vaccin
note
first
introduct
encod
protein
mhc
class
pathway
induc
good
cell
respons
second
case
protein
also
encount
mhc
class
ii
pathway
b
cell
thu
induc
cell
antibodi
respons
third
space
limit
potenti
viral
vector
appli
dna
vaccin
sinc
mani
differ
plasmid
could
contain
singl
vaccin
cocktail
fourth
possibl
manipul
immun
respons
induc
exampl
direct
plasmidencod
protein
select
induc
cell
rodriguez
et
al
rodriguez
et
al
enhanc
induct
cell
rodriguez
whitton
unpublish
data
fifth
dna
vaccin
safe
easi
produc
cheapli
quantiti
high
level
puriti
benefit
led
mani
laboratori
evalu
dna
vaccin
number
anim
model
includ
sever
involv
virus
infect
cn
dna
vaccin
encod
nucleoprotein
np
lcmv
confer
protect
normal
lethal
intracrani
challeng
yokoyama
et
al
zarozinski
et
al
prevent
establish
persist
infect
pedroza
martin
et
al
protect
mediat
depend
induct
antivir
antibodi
vehicl
salin
lipidassoci
rout
administr
import
determin
level
induc
immun
yokoyama
et
al
yokoyama
et
al
lcmv
model
allow
demonstr
exquisit
flexibl
dna
vaccin
lcmv
np
gene
fuse
host
protein
ubiquitin
result
protein
target
rapid
intracellular
degrad
plasmid
encod
ubiquitinnp
fusion
induc
enhanc
protect
intracrani
challeng
rodriguez
et
al
perhap
increas
precursor
frequenc
npspecif
ctl
rodriguez
et
al
addit
lcmv
model
use
studi
neonat
dna
immun
singl
inocul
within
hour
birth
suffici
induc
protect
immun
even
presenc
matern
antibodi
respons
longliv
remark
abund
long
year
postdna
immun
anim
cell
npspecif
hassett
et
al
note
studi
employ
peripher
immun
none
attempt
induc
respons
within
cn
howev
data
indic
follow
intracrani
inocul
viru
dnavaccineinduc
ctl
enter
cn
limit
lcmv
replic
dissemin
investig
util
dna
vaccin
theiler
viru
cdna
encod
viral
capsid
protein
construct
suscept
sjlj
mice
vaccin
intramuscularli
one
two
three
time
dna
vaccin
mice
infect
theiler
viru
clinic
patholog
featur
diseas
follow
interestingli
mice
vaccin
cdna
encod
partial
protect
clinic
patholog
diseas
addit
vaccin
somewhat
abl
amelior
clinic
diseas
infect
mice
vaccin
also
protect
mice
demyelin
diseas
tsunoda
fujinami
unpublish
contrast
mice
vaccin
cdna
encod
sever
clinic
diseas
enhanc
histopatholog
compar
nonvaccin
mice
relationship
antiviru
antibodi
titer
extent
cours
diseas
thu
differ
outcom
observ
depend
viral
antigen
includ
vaccin
dna
vaccin
shown
effect
sever
agent
review
section
rabi
mous
model
immun
plasmid
encod
rabi
glycoprotein
confer
complet
protect
subsequ
viral
challeng
ray
et
al
xiang
et
al
xiang
et
al
protect
also
seen
mice
immun
neonat
wang
et
al
confirm
efficaci
neonat
dna
immun
demonstr
lcmv
model
recent
dna
immun
cynomolgu
monkey
shown
complet
protect
subsequ
challeng
gener
level
antibodi
compar
induc
standard
human
diploid
cell
vaccin
j
lindsay
whitton
robert
fujinami
lodmel
et
al
data
suggest
dna
immun
may
futur
higher
primat
reader
chapter
measl
ampl
evid
show
dna
vaccin
induc
measlesspecif
humor
cellmedi
immun
cardoso
et
al
furthermor
neonat
import
target
measl
vaccin
dna
immun
age
induc
measlesspecif
ctl
martinez
et
al
although
wide
use
small
anim
model
measlesinduc
postinfecti
encephalomyel
sspe
intracrani
measl
viru
inocul
caus
enceph
diseas
abrog
prior
dna
immun
plasmidencod
measl
nucleoprotein
hsu
et
al
recent
transgen
mous
line
develop
express
measl
viru
receptor
neuron
rall
et
al
provid
opportun
evalu
effect
measlesspecif
immun
respons
cn
lawrenc
et
al
dna
vaccin
also
effect
anim
model
combat
variou
arbovir
encephalitid
includ
st
loui
enceph
konishi
et
al
phillpott
et
al
japanes
enceph
ashok
rangarajan
konishi
et
al
lin
et
al
la
cross
enceph
schuh
et
al
murray
valley
enceph
colombag
et
al
sever
virusinduc
cn
diseas
may
explain
trigger
autoimmun
experiment
autoimmun
encephalomyel
eae
wellcharacter
cn
diseas
induc
administr
certain
cn
protein
epitop
protein
shown
peripher
immun
recombin
vaccinia
virus
plasmid
dna
encod
cn
protein
epitop
radic
alter
suscept
host
eae
barnett
et
al
barnett
et
al
tsunoda
et
al
thu
establish
potenti
vaccin
autoimmun
phenomena
howev
vaccin
plasmid
dna
alon
potenti
eae
theiler
viru
demyelin
diseas
like
due
immunostimulatori
cpg
motif
contain
bacteri
dna
tse
rare
human
present
major
medic
interest
probabl
come
risk
interspeci
transfer
human
hypothes
number
unusu
case
cjd
young
briton
result
expos
product
cattl
carri
bovin
spongiform
encephalopathi
although
problem
may
partial
address
cull
infect
herd
investig
interspeci
transfer
remain
import
pool
offal
render
product
although
longer
fed
anim
directli
human
foodchain
case
use
make
product
us
intim
expos
cosmet
exampl
thu
despit
rariti
tse
prospect
abl
immun
excit
infecti
agent
stimul
antigenspecif
host
immun
respons
current
dogma
suggest
host
immun
play
littl
role
pathogenesi
tse
inde
sinc
infecti
protein
hostencod
might
expect
immun
respons
would
mount
consist
mous
tse
agent
inocul
normal
mice
appear
induc
limit
immun
respons
thu
might
appear
pointless
pursu
idea
vaccin
selfprotein
howev
possibl
relev
immunolog
modif
prion
diseas
alzheim
diseas
may
result
cn
deposit
misfold
amyloid
protein
immun
protein
precursor
fragment
cours
selfprotein
slow
develop
characterist
neuropatholog
chang
schenk
et
al
rais
possibl
immun
respons
prp
might
alter
diseas
cours
furthermor
steroid
appear
reduc
suscept
tse
outram
et
al
recent
find
indic
cell
infiltr
may
occur
earli
indic
tse
betmouni
et
al
although
antigenspecif
cell
defin
dna
immun
offer
promis
tool
evalu
relev
prionspecif
immun
respons
induc
cell
may
even
abl
overcom
nonrespond
statu
host
schirmbeck
et
al
fact
dna
immun
prpko
mice
inde
induc
antiprp
antibodi
cell
respons
pursu
krasemann
et
al
might
dna
immun
protect
diseas
vaccin
interspeci
transfer
might
exacerb
diseas
prime
immunopatholog
studi
way
one
laboratori
jlw
